{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:58:32Z","timestamp":1791417512580,"version":"4.3.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T00:00:00Z","timestamp":1461542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1038\/ng.3557","type":"journal-article","created":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T16:56:23Z","timestamp":1461603383000},"page":"600-606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":410,"title":["Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors"],"prefix":"10.1038","volume":"48","author":[{"given":"Jaegil","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent W","family":"Mouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paz","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior Z","family":"Braunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atanas","family":"Kamburov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Tiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Kwiatkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer M","family":"Van Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D","family":"D'Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Getz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,25]]},"reference":[{"key":"BFng3557_CR1","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609\u2013615 (2011).","DOI":"10.1038\/nature10166"},{"key":"BFng3557_CR2","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.tig.2014.06.003","volume":"30","author":"F Dietlein","year":"2014","unstructured":"Dietlein, F., Thelen, L. & Reinhardt, H.C. Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches. Trends Genet. 30, 326\u2013339 (2014).","journal-title":"Trends Genet."},{"key":"BFng3557_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2013.03.002","volume":"153","author":"LA Garraway","year":"2013","unstructured":"Garraway, L.A. & Lander, E.S. Lessons from the cancer genome. Cell 153, 17\u201337 (2013).","journal-title":"Cell"},{"key":"BFng3557_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L.B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"BFng3557_CR5","doi-asserted-by":"publisher","first-page":"8866","DOI":"10.1038\/ncomms9866","volume":"6","author":"S Kasar","year":"2015","unstructured":"Kasar, S. et al. Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution. Nat. Commun. 6, 8866 (2015).","journal-title":"Nat. Commun."},{"key":"BFng3557_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrg3729","volume":"15","author":"T Helleday","year":"2014","unstructured":"Helleday, T., Eshtad, S. & Nik-Zainal, S. Mechanisms underlying mutational signatures in human cancers. Nat. Rev. Genet. 15, 585\u2013598 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"BFng3557_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrm3822","volume":"15","author":"JA Marteijn","year":"2014","unstructured":"Marteijn, J.A., Lans, H., Vermeulen, W. & Hoeijmakers, J.H. Understanding nucleotide excision repair and its roles in cancer and ageing. Nat. Rev. Mol. Cell Biol. 15, 465\u2013481 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFng3557_CR8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence, M.S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214\u2013218 (2013).","journal-title":"Nature"},{"key":"BFng3557_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.dnarep.2011.04.028","volume":"10","author":"JO Fuss","year":"2011","unstructured":"Fuss, J.O. & Tainer, J.A. XPB and XPD helicases in TFIIH orchestrate DNA duplex opening and damage verification to coordinate repair with transcription and cell cycle via CAK kinase. DNA Repair (Amst.) 10, 697\u2013713 (2011).","journal-title":"DNA Repair (Amst.)"},{"key":"BFng3557_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrm3350","volume":"13","author":"E Compe","year":"2012","unstructured":"Compe, E. & Egly, J.M. TFIIH: when transcription met DNA repair. Nat. Rev. Mol. Cell Biol. 13, 343\u2013354 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFng3557_CR11","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315\u2013322 (2014).","DOI":"10.1038\/nature12965"},{"key":"BFng3557_CR12","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1158\/2159-8290.CD-14-0623","volume":"4","author":"EM Van Allen","year":"2014","unstructured":"Van Allen, E.M. et al. Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma. Cancer Discov. 4, 1140\u20131153 (2014).","journal-title":"Cancer Discov."},{"key":"BFng3557_CR13","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/ng.2798","volume":"45","author":"G Guo","year":"2013","unstructured":"Guo, G. et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat. Genet. 45, 1459\u20131463 (2013).","journal-title":"Nat. Genet."},{"key":"BFng3557_CR14","doi-asserted-by":"publisher","first-page":"6605","DOI":"10.1158\/1078-0432.CCR-14-0257","volume":"20","author":"KL Yap","year":"2014","unstructured":"Yap, K.L. et al. Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent mutations of UNC5C and prognostic importance of DNA repair gene mutations on survival. Clin. Cancer Res. 20, 6605\u20136617 (2014).","journal-title":"Clin. Cancer Res."},{"key":"BFng3557_CR15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jama.2011.1142","volume":"306","author":"ND Freedman","year":"2011","unstructured":"Freedman, N.D., Silverman, D.T., Hollenbeck, A.R., Schatzkin, A. & Abnet, C.C. Association between smoking and risk of bladder cancer among men and women. J. Am. Med. Assoc. 306, 737\u2013745 (2011).","journal-title":"J. Am. Med. Assoc."},{"key":"BFng3557_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00345-009-0383-3","volume":"27","author":"M Ploeg","year":"2009","unstructured":"Ploeg, M., Aben, K.K. & Kiemeney, L.A. The present and future burden of urinary bladder cancer in the world. World J. Urol. 27, 289\u2013293 (2009).","journal-title":"World J. Urol."},{"key":"BFng3557_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/mutage\/geg020","volume":"18","author":"S Benhamou","year":"2003","unstructured":"Benhamou, S. et al. DNA adducts in normal bladder tissue and bladder cancer risk. Mutagenesis 18, 445\u2013448 (2003).","journal-title":"Mutagenesis"},{"key":"BFng3557_CR18","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.18632\/oncotarget.1954","volume":"5","author":"HW Lee","year":"2014","unstructured":"Lee, H.W. et al. Acrolein- and 4-aminobiphenyl-DNA adducts in human bladder mucosa and tumor tissue and their mutagenicity in human urothelial cells. Oncotarget 5, 3526\u20133540 (2014).","journal-title":"Oncotarget"},{"key":"BFng3557_CR19","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1073\/pnas.88.12.5350","volume":"88","author":"G Talaska","year":"1991","unstructured":"Talaska, G., al-Juburi, A.Z. & Kadlubar, F.F. Smoking related carcinogen\u2013DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc. Natl. Acad. Sci. USA 88, 5350\u20135354 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng3557_CR20","first-page":"257","volume":"24","author":"W Gao","year":"2010","unstructured":"Gao, W. et al. Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk. Oncol. Rep. 24, 257\u2013262 (2010).","journal-title":"Oncol. Rep."},{"key":"BFng3557_CR21","doi-asserted-by":"publisher","first-page":"6857","DOI":"10.1158\/0008-5472.CAN-09-1091","volume":"69","author":"MC Stern","year":"2009","unstructured":"Stern, M.C. et al. Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the International Consortium of Bladder Cancer. Cancer Res. 69, 6857\u20136864 (2009).","journal-title":"Cancer Res."},{"key":"BFng3557_CR22","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1109\/TPAMI.2012.240","volume":"35","author":"VY Tan","year":"2013","unstructured":"Tan, V.Y. & F\u00e9votte, C. Automatic relevance determination in nonnegative matrix factorization with the \u03b2-divergence. IEEE Trans. Pattern Anal. Mach. Intell. 35, 1592\u20131605 (2013).","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"BFng3557_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ng.2955","volume":"46","author":"S Nik-Zainal","year":"2014","unstructured":"Nik-Zainal, S. et al. Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer. Nat. Genet. 46, 487\u2013491 (2014).","journal-title":"Nat. Genet."},{"key":"BFng3557_CR24","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/ng.2702","volume":"45","author":"SA Roberts","year":"2013","unstructured":"Roberts, S.A. et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 45, 970\u2013976 (2013).","journal-title":"Nat. Genet."},{"key":"BFng3557_CR25","doi-asserted-by":"publisher","first-page":"197ra101","DOI":"10.1126\/scitranslmed.3006086","volume":"5","author":"SL Poon","year":"2013","unstructured":"Poon, S.L. et al. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool. Sci. Transl. Med. 5, 197ra101 (2013).","journal-title":"Sci. Transl. Med."},{"key":"BFng3557_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/carcin\/9.2.297","volume":"9","author":"HH Schmeiser","year":"1988","unstructured":"Schmeiser, H.H., Schoepe, K.B. & Wiessler, M. DNA adduct formation of aristolochic acid I and II in vitro and in vivo. Carcinogenesis 9, 297\u2013303 (1988).","journal-title":"Carcinogenesis"},{"key":"BFng3557_CR27","doi-asserted-by":"publisher","first-page":"197ra102","DOI":"10.1126\/scitranslmed.3006200","volume":"5","author":"ML Hoang","year":"2013","unstructured":"Hoang, M.L. et al. Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing. Sci. Transl. Med. 5, 197ra102 (2013).","journal-title":"Sci. Transl. Med."},{"key":"BFng3557_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13073-015-0161-3","volume":"7","author":"SL Poon","year":"2015","unstructured":"Poon, S.L. et al. Mutation signatures implicate aristolochic acid in bladder cancer development. Genome Med. 7, 38 (2015).","journal-title":"Genome Med."},{"key":"BFng3557_CR29","doi-asserted-by":"publisher","first-page":"E5486","DOI":"10.1073\/pnas.1516373112","volume":"112","author":"A Kamburov","year":"2015","unstructured":"Kamburov, A. et al. Comprehensive assessment of cancer missense mutation clustering in protein structures. Proc. Natl. Acad. Sci. USA 112, E5486\u2013E5495 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng3557_CR30","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar, P., Henikoff, S. & Ng, P.C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073\u20131081 (2009).","journal-title":"Nat. Protoc."},{"key":"BFng3557_CR31","doi-asserted-by":"publisher","first-page":"7435","DOI":"10.1038\/sj.onc.1205803","volume":"21","author":"GP Pfeifer","year":"2002","unstructured":"Pfeifer, G.P. et al. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21, 7435\u20137451 (2002).","journal-title":"Oncogene"},{"key":"BFng3557_CR32","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/ng.3292","volume":"47","author":"LC Francioli","year":"2015","unstructured":"Francioli, L.C. et al. Genome-wide patterns and properties of de novo mutations in humans. Nat. Genet. 47, 822\u2013826 (2015).","journal-title":"Nat. Genet."},{"key":"BFng3557_CR33","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ng1103","volume":"33","author":"P Green","year":"2003","unstructured":"Green, P. et al. Transcription-associated mutational asymmetry in mammalian evolution. Nat. Genet. 33, 514\u2013517 (2003).","journal-title":"Nat. Genet."},{"key":"BFng3557_CR34","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.cell.2015.12.050","volume":"164","author":"NJ Haradhvala","year":"2016","unstructured":"Haradhvala, N.J. et al. Mutational strand asymmetries in cancer genomes reveal mechanisms of DNA damage and repair. Cell 164, 538\u2013549 (2016).","journal-title":"Cell"},{"key":"BFng3557_CR35","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1101\/gr.076570.108","volume":"18","author":"P Polak","year":"2008","unstructured":"Polak, P. & Arndt, P.F. Transcription induces strand-specific mutations at the 5\u2032 end of human genes. Genome Res. 18, 1216\u20131223 (2008).","journal-title":"Genome Res."},{"key":"BFng3557_CR36","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/ng.3441","volume":"47","author":"LB Alexandrov","year":"2015","unstructured":"Alexandrov, L.B. et al. Clock-like mutational processes in human somatic cells. Nat. Genet. 47, 1402\u20131407 (2015).","journal-title":"Nat. Genet."},{"key":"BFng3557_CR37","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.eururo.2015.01.014","volume":"69","author":"FH Groenendijk","year":"2016","unstructured":"Groenendijk, F.H. et al. ERBB2 mutations characterize a subgroup of muscle-invasive bladder cancers with excellent response to neoadjuvant chemotherapy. Eur. Urol. 69, 384\u2013388 (2016).","journal-title":"Eur. Urol."},{"key":"BFng3557_CR38","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.eururo.2015.07.009","volume":"68","author":"ER Plimack","year":"2015","unstructured":"Plimack, E.R. et al. Defects in DNA repair genes predict response to neoadjuvant cisplatin-based chemotherapy in muscle-invasive bladder cancer. Eur. Urol. 68, 959\u2013967 (2015).","journal-title":"Eur. Urol."},{"key":"BFng3557_CR39","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/annonc\/mdl435","volume":"18","author":"J Bellmunt","year":"2007","unstructured":"Bellmunt, J. et al. Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy. Ann. Oncol. 18, 522\u2013528 (2007).","journal-title":"Ann. Oncol."},{"key":"BFng3557_CR40","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1200\/JCO.2007.13.5806","volume":"26","author":"CS Walsh","year":"2008","unstructured":"Walsh, C.S. et al. ERCC5 is a novel biomarker of ovarian cancer prognosis. J. Clin. Oncol. 26, 2952\u20132958 (2008).","journal-title":"J. Clin. Oncol."},{"key":"BFng3557_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.dnarep.2015.01.001","volume":"29","author":"JG Jansen","year":"2015","unstructured":"Jansen, J.G., Tsaalbi-Shtylik, A. & de Wind, N. Roles of mutagenic translesion synthesis in mammalian genome stability, health and disease. DNA Repair (Amst.) 29, 56\u201364 (2015).","journal-title":"DNA Repair (Amst.)"},{"key":"BFng3557_CR42","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrm3289","volume":"13","author":"JE Sale","year":"2012","unstructured":"Sale, J.E., Lehmann, A.R. & Woodgate, R. Y-family DNA polymerases and their role in tolerance of cellular DNA damage. Nat. Rev. Mol. Cell Biol. 13, 141\u2013152 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFng3557_CR43","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979\u2013993 (2012).","journal-title":"Cell"},{"key":"BFng3557_CR44","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1038\/ncomms5114","volume":"5","author":"G Strona","year":"2014","unstructured":"Strona, G., Nappo, D., Boccacci, F., Fattorini, S. & San-Miguel-Ayanz, J. A fast and unbiased procedure to randomize ecological binary matrices with fixed row and column totals. Nat. Commun. 5, 4114 (2014).","journal-title":"Nat. Commun."},{"key":"BFng3557_CR45","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/44565","volume":"401","author":"DD Lee","year":"1999","unstructured":"Lee, D.D. & Seung, H.S. Learning the parts of objects by non-negative matrix factorization. Nature 401, 788\u2013791 (1999).","journal-title":"Nature"},{"key":"BFng3557_CR46","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng3557_CR47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter, S.L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413\u2013421 (2012).","journal-title":"Nat. Biotechnol."},{"key":"BFng3557_CR48","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","volume":"152","author":"DA Landau","year":"2013","unstructured":"Landau, D.A. et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 152, 714\u2013726 (2013).","journal-title":"Cell"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng.3557.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng.3557","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng.3557.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T21:13:24Z","timestamp":1684444404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng.3557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,25]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["BFng3557"],"URL":"https:\/\/doi.org\/10.1038\/ng.3557","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,25]]},"assertion":[{"value":"8 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.E.R. and E.M.V.A. have a patent pending for use of <i>ERCC2<\/i> mutational status as a predictive biomarker for cisplatin sensitivity.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}